Otsuka Holdings
4578.T
#723
Rank
โ‚น2.408 T
Marketcap
โ‚น4,485
Share price
-1.59%
Change (1 day)
39.13%
Change (1 year)
Otsuka Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company involved in the R&D of drugs and healing methods for respiratory diseases, eye diseases, cardiovascular diseases, neurological and mental diseases as well as Parkinson's, tuberculosis and cancer.

EPS for Otsuka Holdings (4578.T)

EPS in 2023 (TTM): โ‚น200.15

According to Otsuka Holdings 's latest financial reports the company's current EPS (TTM) is โ‚น211.19. In 2022 the company made an earnings per share (EPS) of โ‚น159.24 a decrease over its 2021 EPS that were of โ‚น181.74.

EPS history for Otsuka Holdings from 2010 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น200.1525.69%
2022โ‚น159.24-12.38%
2021โ‚น181.74-18.58%
2020โ‚น223.2018.81%
2019โ‚น187.8755.85%
2018โ‚น120.55-25.05%
2017โ‚น160.8310.15%
2016โ‚น146.017.74%
2015โ‚น135.52-39.2%
2014โ‚น222.89-20.14%
2013โ‚น279.1051.58%
2012โ‚น184.13-6.65%
2011โ‚น197.2529.28%
2010โ‚น152.58